Time: 9:59 am
day: Track B - Pre-conf-AM


Maximizing the clinical therapeutic index of ADCs still remains the main focus for those working in this industry. Reducing
toxicity is a key part of that, and challenges surrounding understanding the causes of offtarget toxicity, examining how well toxicities translate into humans and discussing the relationship between PK and toxicity are just a couple of questions that are front of mind. This day will bring together
toxicology experts to help explain, understand and create strategies to mitigate toxicities.